Search - tctmd.com

Displaying 21 - 40 of 55

Sort: Relevancy | Date

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Industry News

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

August 27, 2018

News Conference News ESC 2018

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

Todd Neale

August 27, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Daily News

Diversity in Heart Failure Trials Still Falls Short

Todd Neale

August 22, 2018

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

L.A. McKeown

August 20, 2018

News Opinion Fellow Talk

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Yashasvi Chugh, MD

August 16, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

News Conference News The Structural Heart Disease Summit 2018

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Michael O'Riordan

June 27, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

L.A. McKeown

May 15, 2018

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

News Conference News SCAI 2018

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Yael L. Maxwell

April 26, 2018

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

News Conference News ACC 2018

Wearable Cardioverter-Defibrillator Fails to Meet Primary Endpoint in First Randomized Trial

Todd Neale

March 10, 2018

News Conference News CRT 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Shelley Wood

March 07, 2018

Advertisement

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

MITRA-FR: No Benefit of MitraClip in Functional MR

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Diversity in Heart Failure Trials Still Falls Short

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Uncomplicated TLR After PCI Linked With Worse Mortality

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Wearable Cardioverter-Defibrillator Fails to Meet Primary Endpoint in First Randomized Trial

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content